Quarterly report pursuant to Section 13 or 15(d)

The following securities were not included in the computation of diluted shares outstanding for the three and nine months ended September 30, 2023, and 2022 because the effect would be anti-dilutive: (Details)

v3.23.3
The following securities were not included in the computation of diluted shares outstanding for the three and nine months ended September 30, 2023, and 2022 because the effect would be anti-dilutive: (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Accounting Policies [Abstract]        
Common stock options 72,347 4,047 81,723
PSUs 54,496 54,496
Restricted stock 850,000 950,000 850,000 950,000
Total 904,496 1,022,347 908,543 1,031,723